Gene · 3636
Papers1,456
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,456
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| When X Does Not Mark the Spot: Autosomal Dominant and Recessive Forms of Renal Hypophosphatemic Rickets and Osteomalacia. | Curr Osteoporos Rep | 2026 | 42412262 | PubTator, text mining | PubMed |
| LPIN3 emerges as a diagnostic biomarker in Moyamoya disease revealing immune-lipid metabolic crosstalk. | Front Genet | 2026 | 42338983 | PubTator, text mining | PubMed |
| Aimed at Subtype Discrimination but Yielding a Shared Marker: Integrative Analysis of Blood Transcriptomes Reveals Upregulated TLR5 as a Potential Biomarker for IBD. | Clin Exp Gastroenterol | 2026 | 42112146 | PubTator, text mining | PubMed |
| Phosphatidylinositol 3,4-bisphosphate emerges as a lipid mediator linking oxidative stress to DNA damage. | J Biochem | 2026 | 41955560 | PubTator, text mining | PubMed |
| Advances in the biological functions of miR‑205 in various diseases (Review). | Mol Med Rep | 2026 | 41860043 | PubTator, text mining | PubMed |
Active Macropinocytosis, Lipid Catabolism, and Exhausting Immune Microenvironment of Ascites Tumor Cells Are Involved in Resistance to Platinum-Based Therapy in Patients With High-Grade Serous Ovarian Cancer. | MedComm (2020) | 2026 | 41799929 | PubTator, text mining | PubMed |
| Targeted biologics for TNBC: Advances in nanobodies, antibodies, peptides, and aptamers. | Mol Ther Oncol | 2026 | 41716468 | PubTator, text mining | PubMed |
| Interplay between obesity-associated insulin resistance and immune system through the lens of evolutionary medicine. | Mol Metab | 2026 | 41692338 | PubTator, text mining | PubMed |
| Structural insights into SHIP2 reveal its membrane regulatory mechanisms. | Protein Sci | 2026 | 41676923 | PubTator, text mining | PubMed |
| Quantitative MRI Evaluation of Hemispheric Asymmetry in Circle of Willis Artery Diameters. | J Neuroimaging | 2026 | 41635955 | PubTator, text mining | PubMed |
| SH2scan: Mapping SH2 Domain-Ligand Binding Selectivity for Inhibitors and Degraders. | J Med Chem | 2026 | 41543922 | PubTator, text mining | PubMed |
| Helicobacter pylori and Cancer: What's the Link? | Clin Exp Gastroenterol | 2026 | 41531650 | PubTator, text mining | PubMed |
| Pharmacological SHIP2 blockade enhances sensitivity to standard and targeted cancer therapies. | Adv Biol Regul | 2026 | 41198465 | PubTator, text mining | PubMed |
| Pamidronate Treatment of a Patient with Opsismodysplasia and a Novel INPPL1 Variant: Efficacy, Mechanism, and Clinical Outcomes. | Mol Syndromol | 2026 | 40620719 | PubTator, text mining | PubMed |
| SHIP2-PLK1 crosstalk promotes sensitivity to dual inhibition in esophageal squamous cell carcinoma. | Mol Cancer | 2025 | 41188852 | PubTator, text mining | PubMed |
| Beyond the Curtains: Identification of the Genetic Cause of Foetal Developmental Abnormalities Through the Application of Molecular Autopsy. | Genes (Basel) | 2025 | 41153384 | PubTator, text mining | PubMed |
| SH2-mediated steric occlusion of the C2 domain regulates autoinhibition of SHIP1 inositol 5-phosphatase. | bioRxiv | 2025 | 40949984 | PubTator, text mining | PubMed |
| Upregulation of SHIP2 Participates in the Development of Breast Cancer via Promoting Wnt/β-Catenin Signaling [Retraction]. | Onco Targets Ther | 2025 | 40791736 | PubTator, text mining | PubMed |
| Heat stress targets and degrades BCR::ABL1 oncoproteins to overcome drug-resistance in Philadelphia chromosome-positive acute lymphoblastic leukemia. | Leukemia | 2025 | 40696139 | PubTator, text mining | PubMed |
| miR-184 in hepatocellular carcinoma: a promising therapeutic target. | J Physiol Biochem | 2025 | 40668533 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3636/papers